A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT02724735
Study of NSI-189 for Major Depressive Disorder
Phase 2
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2016-03-01
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT02695472
- Locations
- ๐บ๐ธ
Clinical Neuroscience Solutions, Inc., Memphis, Tennessee, United States
๐บ๐ธCollaborative Neuroscience Network, LLC, Garden Grove, California, United States
๐บ๐ธSt. Louis Clinical Trials, LC, St. Louis, Missouri, United States
Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI
Phase 1
- Conditions
- Spinal Cord Injury (SCI)
- Interventions
- Drug: Human spinal cord stem cells.
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01772810
- Locations
- ๐บ๐ธ
UCSD Medical Center, Division of Neurosurgery, San Diego, California, United States
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Phase 2
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Device: Human spinal cord stem cell implantation
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2015-04-20
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01730716
- Locations
- ๐บ๐ธ
Emory University, Atlanta, Georgia, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธUniversity of Michigan, Ann Arbor, Michigan, United States
Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2014-04-02
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT01520649
- Locations
- ๐บ๐ธ
California Clinical Trials, Glendale, California, United States
Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Phase 1
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Device: surgical implantation
- First Posted Date
- 2011-05-05
- Last Posted Date
- 2016-03-10
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01348451
- Locations
- ๐บ๐ธ
Emory University, Atlanta, Georgia, United States
Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2011-11-21
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT01310881
- Locations
- ๐บ๐ธ
California Clinical Trials, Glendale, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath